Background. To study the effect of cannulation time on arteriovenous fistula (AVF) survival. Methods. Analysis of two prospective databases of access operations and dialysis sessions from 12 January 2002 through 4 January 2015 with follow-up until 4 January 2016. First cannulation time (FCT), defined from operation to first cannulation, was categorized as <2 weeks, 2-4 weeks, 4-8 weeks, 8-16 weeks and !16 weeks. Early cannulation was defined as FCT within 4 weeks. AVF survival was defined as the date until the AVF was abandoned. Maximum machine blood flow rate (BFR) for the first 29 dialysis sessions on AVF was analysed. Results. Altogether, 1167 AVF with functional dialysis use were analysed: 667 (57%) radial cephalic AVF, 383 (33%) brachiocephalic AVF and 117 (10%) brachiobasilic AVF. The 631 (54%) AVF created in on-dialysis patients were analysed separately from 536 (46%) AVF created in pre-dialysis patients. AVF survival was similar between cannulation categories for both predialysis patients (P ¼ 0.19) and on-dialysis patients (P ¼ 0.83). Early cannulation was associated with similar AVF survival in both pre-dialysis patients (P ¼ 0.82) and on-dialysis patients (P ¼ 0.17). Six consecutive successful cannulations from the start were associated with improved AVF survival (P ¼ 0.0002). A below-median BFR at the start of dialysis was associated with better AVF survival (P < 0.0001). A below-median increase in BFR in the first 2 months was associated with worse AVF survival (P ¼ 0.007). The type of AVF, diabetes, pre-dialysis state at operation and six successful cannulations from the start were independent predictors for AVF survival. Conclusions. FCT is not associated with AVF survival. Failures to achieve six successful cannulations from the start of dialysis and higher machine BFR in the first week of dialysis are associated with decreased AVF survival.
I N T R O D U C T I O N
Arteriovenous fistulas (AVFs), the preferred form of access for haemodialysis [1, 2] , need time to mature in order to allow safe cannulation without compromising the survival of the access. The American guidelines recommend a minimum wait of 1 month [1] and the European Guidelines recommend a minimum delay of 4 weeks [2] . These recommendations lack firm evidence. Two Dialysis Outcomes and Practice Patterns Study (DOPPS) investigations contradict these recommendations. Rayner [3] found no association between early AVF cannulation, <4 weeks after AVF creation, compared with delayed cannulation and AVF survival, but noticed that first cannulation within 2 weeks of AVF creation was associated with a doubling of the risk of AVF failure [3] . A second DOPPS examined the association between average first cannulation time (FCT) at the facility level, blood flow rates (BFRs) and access failure [4] . This study showed that a facility practice pattern of cannulation within 1 month was not associated with an increased risk of access failure and found no significant differences between blood flow categories and the risk of access failure. The followup in both studies was short, up to 500 days in the first DOPPS [3] and 4 months in the second DOPPS [4] . The first study did not adjust for dialysis state at access creation and the second study used nurses who reported the typical time from creation to first cannulation at their facilities. Therefore, both studies were unable to draw firm conclusions on the association between first cannulation and AVF survival. In contrast, a multicentre study from Italy found that AVF cannulation within 1 month was associated with decreased AVF survival [5] . This study adjusted but did not stratify by dialysis state at AVF creation and had a follow-up of less than 5 years.
Stratifying by dialysis state is essential in patient-level studies looking at the effect of FCT on AVF survival. Patients already on dialysis with a central venous catheter (CVC) tend to have their AVF cannulated earlier, as there are clinical and financial incentives to remove CVCs [6], and AVFs created in patients already on dialysis have worse survival [7] [8] [9] . It is therefore important to distinguish between pre-dialysis patients and patients already on dialysis at AVF creation [8] . This study investigates the relationship between FCT and long-term AVF survival, stratified by dialysis status. We hypothesized that a minimum delay of 4 weeks is not associated with improved AVF survival. We also studied which other modifiable factors are associated with long-term AVF survival.
M A T E R I A L S A N D M E T H O D S
This is a retrospective analysis of two prospectively maintained databases of vascular access operations and dialysis sessions in our centre, with three hospitals, four satellite dialysis units and a home haemodialysis programme, serving an average prevalent dialysis population of 475 patients. The study period was from 1 December 2002, when we started the vascular access database, to 1 April 2015. Follow-up was until 1 April 2016. All operations and dates of operation were corroborated with the Hospital Episodes Statistics (HES) database and electronic patient records. If required, additional information was sought from the home dialysis team, the vascular access coordinators or the dialysis unit.
The methods and access planning protocol have been described elsewhere [7] . We do preoperative venograms in patients with planned AVF below ipsilateral CVCs. Primary failure (PF) is defined as an AVF that failed to achieve six consecutive successful dialysis sessions with two needles.
AVF survival was defined as cumulative patency, that is, fistula survival from operation date to the last needling date before the AVF was abandoned for a new form of access, irrespective of any interventions. An AVF was not coded as failed after a revision if the patient continued to dialyse on the same AVF within three dialysis sessions. An elbow AVF above a forearm AVF was always coded as a new AVF and the forearm AVF as failed even if the new AVF was used within three dialysis sessions.
FCT, defined as the time from operation to the first needling date, was categorized as <2 weeks, 2-4 weeks, 4-8 weeks, 8-16 weeks and !16 weeks. Early cannulation was defined as FCT within 4 weeks after AVF creation. Patients were censored at the last needling date if they died, moved away, underwent successful renal transplantation or switched to peritoneal dialysis. We use metal needles with a back-eye, rope-ladder technique and insert the cannula bevel up. We insert the arterial needle in both the antegrade and retrograde direction depending on patient and fistula factors. A buttonhole technique is only used for fistula with a short cannulable length and is not used for initial fistula cannulations. The decision whether a fistula is ready for cannulation is made by the vascular access coordinators, who are former dialysis nurses with at least 10 years dialysis experience, and is based on clinical criteria such as size and depth of the vein and strength of the thrill, resulting in an overall judgement of ease of cannulation. The experience of our dialysis nurses varies from novices to those with decades of experience. First cannulations of fistulas are performed by nurses with at least 1-year experience.
Diabetes was coded per dialysis database or according to the patient records. The cause of chronic kidney disease (CKD) was coded as diabetic, vascular CKD (hypertensive or renal vascular disease), polycystic kidney disease, autoimmune CKD (glomerulonephritis, vasculitis, immunoglobulin A nephropathy, etc.), post-renal CKD (obstructive urological causes) and other or unknown as per nephrology patient records.
The mode of access and minimum and maximum dialysis machine BFRs of each dialysis session are logged prospectively by the dialysis nurse. Our protocol for starting dialysis on new fistulas is published elsewhere [10] . We start a new AVF with two 17-gauge needles and keep the BFR between 200 and 250 mL/min. AVFs are cannulated with 16-gauge needles in the second week and we try to increase BFR to 250-300 mL/min. The exact pump speed of each dialysis session is decided within these guidelines by the dialysis nurse and depends on examination of the fistula, ease of cannulation of the fistula and progress of the dialysis session. Pump speed and needle size can be increased after 4 weeks, if felt appropriate by the dialysis nurse.
We collected minimum and maximum BFRs for the first 29 dialysis sessions. Our patients have three dialysis sessions per week. Weekly average maximum BFR at the start of dialysis is the mean maximum BFR of the first three dialysis sessions. The weekly average maximum BFR after 2 months is the mean maximum BFR of the last three dialysis sessions. We analysed the effect of machine BFR at the initiation of dialysis on the AVF and the increase of BFR over the first 2 months on long-term AVF survival by comparing survival functions of AVF with starting BFR above and below the median and those with an increase in BFR over the starting months above and below the median.
Statistical analysis
Comparisons of categorical data were made using chi-squared tests. Continuous variables were analysed using a Student's t-test, one-way analysis of variance (ANOVA) or Wilcoxon rank-sum or Kruskal-Wallis tests. Survival data were compared using life table methods and log-rank tests. Multivariate analysis was performed using Cox proportional hazard models for survival data. We did not perform an automated stepwise regression but started with age and sex and added variables to the model according to their association with cumulative patency in the univariate analysis. A variable was kept in the model when the likelihood ratio test was significant at P < 0.05. All statistical calculations were performed using STATA 12 for Macintosh (StataCorp, College Station, TX, USA).
R E S U L T S

Study population
Altogether, 1641 primary AVFs were created during the study period: 972 (59%) radial cephalic (RCAVF), 510 (31%) brachiocephalic (BCAVF) and 159 (10%) brachiobasilic (BBAVF). In 1199 (73%) cases, the AVF was needled and in 442 (27%) cases the AVF was never needled. Of those, 327 (74%) AVF had failed, 12 (3%) were deemed mature but had not been used for dialysis and 103 (23%) had unknown outcomes. Of the 1199 AVFs that were needled, 1170 achieved functional dialysis status, defined as six consecutive dialysis sessions with two needles. We had BFR measurements for 1167
AVFs. These 1167 AVFs were used for analysis: 667 (57%) RCAVF, 383 (33%) BCAVF and 117 (10%) BBAVF. There were 719 (62%) AVF creations in men and 448 (38%) in women and 481 (41%) AVF operations in diabetics. The median age at AVF creation was 66 years (range 22-92). The median wait between referral and assessment was similar for pre-dialysis patients {3.7 weeks [interquartile range (IQR) 2-5.6 weeks]} and those on dialysis [2.9 weeks (IQR 0.9-5), P ¼ 0.70]. The median wait between assessment and operation was 4.3 weeks (IQR 2.4-6.9) for pre-dialysis patients compared with 4.4 weeks (IQR 2.3-7.1) for those on dialysis (P ¼ 0.37).
First cannulation times
FCT varied from 1 day to >5 years. Long waits occurred mainly in pre-dialysis patients with slow decline of renal function. Ten AVFs were needled within 1 week. Nine of those were an AVF created above a previous distal AVF in the same arm. Only 12 (36%) of the 26 AVFs that were needled within 2 weeks had a previous AVF in the same arm. Altogether, 631 AVFs (54%) were created in on-dialysis patients with a CVC and 536 AVFs (46%) were created in pre-dialysis patients.
We stratified our analysis by dialysis state, as FCT in predialysis patients depends on the decline of renal function. FCT was therefore significantly longer in pre-dialysis patients [41 weeks (SD 49)] compared with on-dialysis patients at AVF creation [12 weeks (SD 19), P < 0.001]. Most AVFs in predialysis patients were needled after 16 weeks, compared with within 8 weeks in on-dialysis patients (Table 1) . FCT was similar between the types of AVFs, if separated as pre-dialysis patients (Kruskal-Wallis, P ¼ 0.61) and those on dialysis (Table 2 ; P ¼ 0.43). Some 106 AVFs were created above a 
AVF survival
AVF survival was analysed separately for pre-dialysis patients and on-dialysis patients with a CVC at AVF creation, as AVF survival is better in pre-dialysis patients [7] . AVFs survival was similar across cannulation categories in AVF that were created in both on-dialysis patients (Figure 1a ; log-rank test, P ¼ 0.83) and in pre-dialysis patients (Figure 1b ; log-rank test, P ¼ 0.19).
Early cannulation, i.e. FCT within 4 weeks, did not influence long-term AVF survival either in pre-dialysis patients (Supplementary data, Figure S1a ; log-rank test, P ¼ 0.88) or in on-dialysis patients at AVF creation (Supplementary data, Figure S1b ; log-rank test, P ¼ 0.19). AVF survival was better in AVFs that had six successful cannulations from the start (Figure 2 ; log-rank test, P < 0.001). The proportion of AVF with interrupted cannulations after the start was similar between early (FCT within 4 weeks) and delayed cannulation (P ¼ 0.95), but was lower in AVFs that were cannulated within 2 weeks and those that were cannulated after 16 weeks (15%) compared with all other cannulation categories (30%; P < 0.001; Supplementary data, Table S5 ).
AVF survival was better in men (log-rank test, P ¼ 0.024) and better in non-diabetics (log-rank test, P ¼ 0.047). Multivariate analysis showed that the cause of CKD, type AVF, dialysis state at AVF creation, six successful cannulations from the start and year of FCT were independent predictors of AVF survival (Table 3) . FCT was not an independent predictor of AVF survival. Similarly, early needling, defined as FCT < 4 weeks, was not an independent predictor of AVF survival [hazard ratio 0.73 (95% confidence interval 0.45-1.11)].
Blood flows by cannulation time
Average maximum machine BFRs in the first week of dialysis on the AVF were higher in the early cannulation categories (Table 4 ; Kruskal-Wallis, P < 0.001). BFRs converged by the end of the first month (Table 4 ; Kruskal-Wallis, P ¼ 0.08). Increases in maximum BFR over the 2 months were lower in the early needling groups (Table 4 ; ANOVA, P < 0.001). Belowmedian maximum machine BFR at the start of dialysis on the AVF was associated with better AVF survival (Figure 3 ; logrank test, P < 0.001). AVF survival was not different for aboveor below-median BFRs at 2 months (log-rank test, P ¼ 0.14). Below-median increases in BFRs over the first 2 months were associated with worse long-term AVF survival (Figure 4 ; logrank test, P ¼ 0.007). Above-median BFR in the first week and a below-median increase of BFR over the first 2 months were not independent predictors of AVF survival in a proportional hazards model adjusting for age, sex, type of AVF, diabetes, dialysis state at AVF creation, six successful cannulations from the start, cause of CKD and the year AVF was first needled. 
D I S C U S S I O N
We have shown that early cannulation does not compromise long-term AVF survival in this study where patients were stratified for dialysis state at the time of AVF creation. Dialysis state is an important confounder. We have shown previously that AVF survival is worse in on-dialysis patients [7] . This is likely due to prior CVC use [9] . FCT was significantly shorter in on-dialysis patients. However, we showed that long-term AVF survival is similar across the categories of FCT in both pre-dialysis patients and on-dialysis patients at AVF creation. Similarly, long-term AVF survival was identical for AVFs that were cannulated within 4 weeks compared with AVFs that were cannulated later in both groups. Even cannulation of some AVFs within 2 weeks was not associated with worse long-term survival. Our access planning protocol is published elsewhere [7] . We propose that an AVF can be cannulated whenever clinically feasible rather than being postponed to an arbitrary time limit. We have adopted the policy that an AVF can be cannulated if an experienced dialysis nurse is confident, based on clinical criteria, that an AVF can be needled easily. Our study showed that six successful cannulations from the start is a strong independent predictor for long-term AVF survival. This suggests that an AVF should only be cannulated if a clinically competent person judges the AVF to be ready for cannulation.
Our study confirms the findings of two DOPPS investigations. Strengths of our study are individual case data, stratification by dialysis state and longer follow-up [3, 8] . We collected exact first, sixth consecutive and last needling dates of each AVF, stratified for dialysis state at AVF creation and adjusted for the type of AVF and patient confounders. Similarly, we obtained individual BFR data for each AVF. We studied all AVFs created in our trust and used the same follow-up methods for all cases, limiting bias. We adjusted for changes in vascular access care over the study period [10] by adding the year the AVF was first cannulated to the multivariate model.
A limitation is that this study was performed in one National Health Service trust. Although we studied all dialysis patients in three hospitals, four satellite dialysis units and a home haemodialysis programme, the dialysis care and cannulation culture are influenced by the same trust policies and all dialysis nurses are educated by the same vascular access team [10] . Our conclusions may not be applicable to other settings. For instance, the determination of a competent person that decides whether an AVF is ready for cannulation may vary between institutions. Although our study confirms the findings of two international DOPPS investigations, DOPPS investigated selected dialysis centres in several countries, which may bias their conclusions.
Cannulation technique is an important determinant of AVF survival [11] [12] [13] . Our protocol conforms to a current best practice. We do not record the type of cannulation on our dialysis database, but we predominantly use the rope-ladder technique. We only used the buttonhole technique for AVF with a short cannulable length, currently in 46 (12%) of our prevalent dialysis patients. We do not use the buttonhole technique to initiate dialysis on an AVF. The buttonhole technique is used more often in one satellite unit. We found no significant differences in AVF survival between the different dialysis units, so we do not think the cannulation technique confounds our findings. We recorded the proportions of AVFs with interrupted Mean of weekly average maximum machine BFR in the first week of dialysis (BFR start), weekly average machine BFR after 1 month of dialysis, weekly average at the end of 2 months and increase in mean weekly average machine BFR over the first 2 months of dialysis. Standard deviation of weekly BFR in parentheses. Effect of FCT and machine BF's on fistula survival cannulations from the start. This serves as a proxy for miscannulations, as most miscannulations occur in the first three dialysis sessions [12] . Early and very late cannulation had the lowest proportion of interrupted cannulations. The associations of machine BFRs and AVF survival are conflicting. The AVFs that were needled early were able to sustain slightly higher machine BFRs in the first week of dialysis. These differences disappeared after 2 months. This lends support to our notion that a good AVF can be needled early, since the machine BFRs are set, within guidelines, at the discretion of the dialysis nurse based on clinical parameters and the progress of the dialysis session. Fistulas that were needled earlier tended to have BFRs at the higher end of the guideline range. This is in keeping with a European study that showed a trend towards a survival benefit in established fistulas with higher blood flows [11] . Yet, an above-median BFR in the first week of initiating dialysis seems to be associated with decreased AVF survival. Higher machine blood flows could increase wall shear stress at the needle sites [14] , which could stimulate neointimal hyperplasia and stenosis formation [15, 16] . This suggests there is an optimum BFR and cautions against cranking the BFR up too high in immature fistulas. Further studies are needed to prove this.
An earlier DOPPS investigation found no significant differences in risk of access failure between different BFR categories [4] , but a recent DOPPS investigation showed that higher BFR was strongly and consistently correlated with higher rates of final AVF failure [9] . In contrast, the Fresenius study found a potential survival benefit for AVF able to sustain higher blood flows [11] . Both studies did not study initial machine BFR but BFR in established access. Our study used the average maximum BFR in the first week for each AVF, and all AVFs were subject to similar access care. Our measurements are therefore more accurate for the effect of initial BFR. The association between a smaller increase in BFR over the first 2 months and decreased AVF survival could indicate that an AVF with belowaverage increases in BFR over the first 2 months are unable to increase the fistula flow sufficiently, which could indicate an increased risk of AVF failure. Unfortunately, we do not have direct AVF flow measurements to prove this. Further studies with direct AVF flow measurements could show whether suboptimal increases in machine BFR are useful as a monitoring tool to select fistulas that are more likely to fail.
C O N C L U S I O N S
We have shown that a shorter time to first cannulation is not associated with decreased AVF survival, but failure to achieve six successful cannulations from the start of dialysis, and higher machine BFR in the first week of dialysis on the AVF is associated with lower AVF survival.
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